Related Experiment Video

Updated: May 1, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

13.1K

P21 activated kinase 4 binds translation elongation factor eEF1A1 to promote gastric cancer cell migration and

Xiang Li1, Jiabin Li1, Feng Li1

  • 1Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, Liaoning, P.R. China.

Oncology Reports
|April 11, 2017
PubMed

Insights

P21 activated kinase 4 (PAK4) interacts with eukaryotic elongation factor 1 α1 (eEF1A1) to promote gastric cancer cell migration and invasion. This discovery offers new insights into gastric cancer progression and metastasis mechanisms.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • P21 activated kinase 4 (PAK4) is implicated in cytoskeleton organization and gastric cancer metastasis.
  • The precise mechanisms by which PAK4 drives gastric cancer progression remain incompletely understood.

Purpose of the Study:

  • To identify novel binding partners of PAK4 involved in gastric cancer.
  • To elucidate the functional role of PAK4 and its interaction with eEF1A1 in gastric cancer cell migration and invasion.

Main Methods:

  • Yeast two-hybrid system for identifying protein interactions.
  • GST pull-down and co-immunoprecipitation assays to confirm binding.
  • Western blotting and immunohistochemistry to analyze protein expression in clinical samples.

Main Results:

  • Eukaryotic elongation factor 1 α1 (eEF1A1) was identified as a novel binding partner of PAK4.
  • PAK4 and eEF1A1 co-localize in the cytoplasm and mutually enhance each other's expression.
  • Co-expression of PAK4 and eEF1A1 significantly promotes gastric cancer cell migration and invasion.
  • A positive correlation was observed between PAK4 and eEF1A1 expression in clinical gastric cancer samples.

Conclusions:

  • PAK4 interacts with eEF1A1 to promote gastric cancer cell migration and invasion.
  • This interaction provides new molecular insights into the progression of gastric cancer.
  • PAK4 and eEF1A1 represent potential therapeutic targets for inhibiting gastric cancer metastasis.

More Related Videos

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

6.2K
Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

2.5K

Related Concept Videos

Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
24.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K